中文Recently, igenesis's Automated Fully Enclosed qPCR System,Galaxy Nano and Galaxy Lite, have both obtained Thailand's medical device TFDA registration and certification, and qualified to enter Thailand's medical device market.
Igenesis Automated Fully Enclosed qPCR System-Galaxy Series
Igenesis Fully Automated Closed qPCR System, Galaxy Nano、Galaxy Lite, coupled with iCassette (PCR-fluorescence method), can intelligently complete the whole process from nucleic acid extraction, purification, fluorescent PCR amplification and analysis,with simple operation, truly realising the sample in, results out. Meanwhile, the Galaxy system has higher openness and compatibility, in addition to use Igenesis's own reagents, it can also be compatible with third-party reagents, which brings more application possibilities for users with rich testing items.
Testing Process
Product Advantages
Intelligent
Automate the whole process of fluorescent PCR,Sample in-Result out,Lower operator requirements;
Integrated
Extraction+Amplification+Detection in one,no additional equipment required;
Fully Enclosed
Eliminate sample cross-contamination, no aerosol risk, and biosafety;
Rapid Detection
1~2 hours to get results, shorten turn-around time.
Until June 2023, igenesis has obtained CE mark for 19 reagents and instruments,overseas business is distributed globally, such as Italy, Chile, Malaysia, Spain, Denmark, Hong Kong, China and Europe, South America, Southeast Asia and other regions.In the future, igenesis will always adhere to the corporate philosophy of "integrity, excellence, innovation and win-win",which provide safe, fast, convenient and accurate POCT solutions for our customers，continuously explore the infinite possibilities of genetic testing.
Post time: Aug-18-2023